Hoge Stephen 4

4 · Moderna, Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4

Period: 2026-02-27

Moderna, Inc.MRNA

Hoge Stephen

President

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-27+652→ 1,458,079 total
Tax Payment
Common Stock
[F2]
2026-02-27$51.71/sh−316$16,340→ 1,457,763 total
Exercise/Conversion
Common Stock
[F1]
2026-02-27+611→ 1,458,374 total
Tax Payment
Common Stock
[F2]
2026-02-27$51.71/sh−296$15,306→ 1,458,078 total
Exercise/Conversion
Common Stock
[F1]
2026-02-27+1,436→ 1,459,514 total
Tax Payment
Common Stock
[F2]
2026-02-27$51.71/sh−695$35,938→ 1,458,819 total
Exercise/Conversion
Common Stock
[F1]
2026-02-27+37,131→ 1,495,950 total
Tax Payment
Common Stock
[F2]
2026-02-27$51.71/sh−17,953$928,350→ 1,477,997 total
Exercise/Conversion
Restricted Stock Units
[F1][F4]
2026-02-27−652→ 0 total
→ Common Stock (652 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F5]
2026-02-27−611→ 2,442 total
→ Common Stock (611 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F6]
2026-02-27−1,436→ 11,495 total
→ Common Stock (1,436 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F7]
2026-02-27−37,131→ 111,393 total
→ Common Stock (37,131 underlying)
Award
Stock Option (Right to Buy)
[F8]
2026-03-01+125,466→ 125,466 total
Exercise: $53.57From: 2027-03-01Exp: 2036-03-01→ Common Stock (125,466 underlying)
Award
Restricted Stock Units
[F1][F9]
2026-03-01+165,230→ 165,230 total
→ Common Stock (165,230 underlying)

Holdings

Common Stock
(indirect: By LLC)
4,116
Common Stock
[F3]
(indirect: By Trust)
151,933

Footnotes (9)

[F1]Restricted stock units convert into common stock on a one-for-one basis.
[F2]Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
[F3]These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
[F4]25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F5]25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F6]25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F7]25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F8]25% of this option will vest and become exercisable on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F9]25% of the shares subject to this restricted stock unit award will vest on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Signature

/s/ James Dillon, as Attorney-in-Fact|2026-03-03

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT